Casdin Capital, LLC Portfolio Holdings

Casdin Capital, LLC

  • $1.16 Billion
  • Q4 2024

Casdin Capital, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.16 Billion distributed in 39 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Biolife Solutions Inc with a value of $226M, Revolution Medicines, Inc. with a value of $162M, Sarepta Therapeutics, Inc. with a value of $131M, Standard Biotools Inc. with a value of $125M, and Illumina, Inc. with a value of $100M.

Examining the 13F form we can see an decrease of $125M in the current position value, from $1.29B to 1.16B.

Casdin Capital, LLC is based out at New York, NY

Below you can find more details about Casdin Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.16 Billion
Healthcare: $1.16 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.19B
$226 Million 19.45% of portfolio
8,707,165
Q4 2023 Added 11.92%
$3.57B
$162 Million 13.92% of portfolio
3,699,283
Q4 2024 Reduced 10.09%
$9.45B
$131 Million 11.23% of portfolio
1,073,500
Q2 2024 Added 0.42%
$110M
$125 Million 10.73% of portfolio
71,254,677
Q3 2024 Added 11.41%
$15.8B
$100 Million 8.62% of portfolio
750,000
Q3 2024 Added 56.25%
$1.68B
$59.5 Million 5.12% of portfolio
2,045,000
Q4 2024 Reduced 1.91%
$282M
$38.6 Million 3.32% of portfolio
8,100,000
Q3 2024 Added 305.0%
$481M
$36.9 Million 3.17% of portfolio
8,948,574
Q4 2024 Reduced 3.27%
$8.73B
$36.5 Million 3.14% of portfolio
650,000
Q1 2024 Added 54.76%
$31.6B
$32.9 Million 2.83% of portfolio
140,000
Q4 2024 Reduced 17.65%
$2.28B
$31 Million 2.67% of portfolio
1,250,000
Q4 2024 Added 61.29%
$5.61B
$28.5 Million 2.45% of portfolio
326,378
Q4 2023 Reduced 12.12%
$813M
$23.3 Million 2.01% of portfolio
2,000,000
Q2 2024 Added 6.67%
$514M
$22.5 Million 1.94% of portfolio
3,995,571
Q3 2024 Added 30.61%
$2.87B
$20.2 Million 1.74% of portfolio
990,000
Q3 2024 Reduced 23.85%
$2.94B
$10.9 Million 0.94% of portfolio
276,308
Q4 2024 Reduced 58.53%
$49.6M
$9.63 Million 0.83% of portfolio
6,732,971
Q1 2024 Added 5.51%
$1.82B
$8.22 Million 0.71% of portfolio
250,000
Q4 2024 New
$12.9B
$7.28 Million 0.63% of portfolio
175,000
Q4 2024 New
$158M
$6.41 Million 0.55% of portfolio
1,150,000
Q3 2024 Added 43.75%
$844M
$6.28 Million 0.54% of portfolio
475,000
Q3 2024 Added 216.67%
$96.2M
$5.88 Million 0.51% of portfolio
2,000,000
Q1 2024 Added 69.12%
$45.3M
$5.24 Million 0.45% of portfolio
5,190,506
Q4 2024 Added 61.58%
$218M
$3.67 Million 0.32% of portfolio
1,188,349
Q4 2023 Reduced 9.1%
$540M
$2.55 Million 0.22% of portfolio
973,260
Q3 2023 Reduced 28.87%
$416M
$1.9 Million 0.16% of portfolio
1,035,859
Q3 2023 New
$1.9B
$1.12 Million 0.1% of portfolio
165,323
Q4 2024 New
$272M
$1.07 Million 0.09% of portfolio
367,175
Q2 2023 Reduced 50.0%
$317M
$596,000 0.05% of portfolio
86,014
Q3 2024 Reduced 67.05%
$57.9M
$117,000 0.01% of portfolio
123,839
Q2 2022 Reduced 78.77%
Genedx Holdings Corp
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 0.55%
Ginkgo Bioworks Holdings Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Contineum Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 37.32%
Septerna Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Neurogene Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 146.92%
Fortrea Hldgs Inc
-
$0 0.0% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 39
  • Current Value $1.16 Billion
  • Prior Value $1.29 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 5 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email